Literature DB >> 7189261

Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.

K Oda, I Goto, Y Kuroiwa, K Onoue, Y Ito.   

Abstract

Serum antibodies to acetylcholine receptors (AChR) in myasthenia gravis were surveyed by radioimmunoassay, using 125I-alpha-bungarotoxin-complexed receptors of human muscles and denervated rat muscles. Antibodies were detected more frequently with human AChR than with rat AChR. Furthermore, antibody titers to human AChR were not always parallel to titers observed in the rat receptors, indicating the heterogeneity of antibody specificities in different individuals. Correlation between antibody titers and clinical severity was better when the antibody concentration was determined with human AChR. About 90% of the myasthenic sera contained antibodies to AChR, and 40% also contained other antibodies such as thyroid autoantibodies. These findings suggest that myasthenia gravis is a multiple immunopathy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189261     DOI: 10.1212/wnl.30.5.543

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

Authors:  N Sommer; B Sigg; A Melms; M Weller; K Schepelmann; V Herzau; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

2.  Anti-acetylcholine receptor antibody measurement in myasthenia gravis.

Authors:  T Brenner; I Wirguin; O Abramsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

3.  Myasthenia gravis: antibodies to acetylcholine receptor in ocular myasthenia gravis.

Authors:  K Oda; Y Ito
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

4.  Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.

Authors:  A Vincent; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

Review 5.  Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.

Authors:  N Sommer; A Melms; M Weller; J Dichgans
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

6.  A lipid-associated acetylcholine receptor as an antigen in diagnosis of myasthenia gravis.

Authors:  F Raimond; B Vernet-der-Garabedian; E Morel
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.